Antitumor agent-2

CAS No. 1351163-57-9

Antitumor agent-2( —— )

Catalog No. M32783 CAS No. 1351163-57-9

Antitumor agent-2 has anti-inflammatory and anti-tumor activity and can be used to study cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 532 Get Quote
5MG 922 Get Quote
10MG 1140 Get Quote
25MG 1463 Get Quote
50MG 1822 Get Quote
100MG 2250 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Antitumor agent-2
  • Note
    Research use only, not for human use.
  • Brief Description
    Antitumor agent-2 has anti-inflammatory and anti-tumor activity and can be used to study cancer.
  • Description
    Antitumor agent-2 is sourced from patent CN102250203, compound 6a-r, has antitumor action and anti-inflammatory action.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1351163-57-9
  • Formula Weight
    558.71
  • Molecular Formula
    C33H42N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@@H](C(N[C@H](C(OCC1=CC=CC=C1)=O)C(C)C)=O)(CC(C)C)N2C(C)(C)N3[C@](C2=O)(CC4=C(C3)NC=5C4=CC=CC5)[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Peng, Shiqi, et al. β-carboline amino acid benzyl ester, its preparation and application. Faming Zhuanli Shenqing (2011), CN 102250203 A 20111123.
molnova catalog
related products
  • Kisspeptin 10 (dog)

    Endogenous ligand for the canine KISS1 receptor (Kisspeptin receptor or GPR54). Stimulates section of luteinizing hormone, follicle stimulating hormone and estradiol in vivo.

  • Hemiphroside B

    Hemiphroside B is a natural product for research related to life sciences.

  • 13-Diaminopropane

    13-Diaminopropane is a common synthesis reagent used in the synthesis of cholinesterase inhibitors and thrombosis inhibitors.